Clinical Trial Update: Effectiveness, Safety and Feasibility of Auxiliary Nurse Midwives' (ANM) Use of Oxytocin in Uniject™ to Prevent Postpartum Hemorrhage in India [NA]

View source ↗

Summary

The clinical trial evaluating the effectiveness, safety, and feasibility of administering oxytocin via Uniject by auxiliary nurse midwives to prevent postpartum…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage

Drugs mentioned

• Oxytocin in Uniject (oxytocin)

Snippet

Sponsor: Johns Hopkins Bloomberg School of Public Health | Conditions: Postpartum Hemorrhage | NA | Status: WITHDRAWN